ES2104156T3 - Peptido estimulante de linfocitos t citotoxicos especificos de virus de la hepatitis c. - Google Patents

Peptido estimulante de linfocitos t citotoxicos especificos de virus de la hepatitis c.

Info

Publication number
ES2104156T3
ES2104156T3 ES93915244T ES93915244T ES2104156T3 ES 2104156 T3 ES2104156 T3 ES 2104156T3 ES 93915244 T ES93915244 T ES 93915244T ES 93915244 T ES93915244 T ES 93915244T ES 2104156 T3 ES2104156 T3 ES 2104156T3
Authority
ES
Spain
Prior art keywords
peptide
ctl
cat
recognize
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93915244T
Other languages
English (en)
Inventor
Jay A Berzofsky
Mutsunori Shirai
Toshitaka Akatsuka
Stephen M Feinstone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2104156T3 publication Critical patent/ES2104156T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA CELULA T CITOTOXICA SENSIBLE A LA PROTEINA CODIFICADA POR LA REGION NS5 DEL VIRUS C DE LA HEPATITIS ERA DETERMINADO USANDO 28 PEPTIDOS DE NS5 QUE FUERON SELECCIONADOS POR UN ALGORITMO DE ANFIPATICIDAD COMO CANDIDATOS PARA LOS EPITOPES DE LA CELULA T. EN EL RATON BALB/C, UN EPITOPE SIMPLE RELATIVAMENTE CONSERVADO REPRESENTADO POR UN PEPTIDO SINTETICO DE RESIDUO-16 ERA REPRESENTADO POR LAS MOLECULAS (MHC) DEL COMPLEJO DE HISTOCOMPATIBILIDAD MAYOR DE CLASE I DD AL CONVENCIONAL CD4-CD8+CTL. UN PEPTIDO EJEMPLAR, QUE REPRESENTA LOS RESIDUOS DE ACIDO AMINO 2422-2437 DE LA POLIPROTEINA DEL CHIRON HCV1 AISLADO, TENIA LA SECUENCIA DE ACIDO AMINO MSYSWTGALVTPCAAE (SEQ ID NO:1). UNA LINEA CTL ESPECIFICA PARA ESTE PEPTIDO RECONOCIDA LAS DOS VARIANTES NATURALES CONOCIDAS DE ESTA SECUENCIA NS5, CADA UNA CON SUSTITUCIONES CONSERVADORAS. ASI, EL CTL PUEDE RECONOCER EL PRODUCTO DEL GEN HCV NS5, LA POLIMERASA RNA PROBABLE, EN ASOCIACION CON LAS MOLECULAS MHC DE CLASE I EN LAS CELULAS OBJETO DE MODELO Y DEBEN RECONOCER AL MISMO EPITOPE EN LOS HEPATOCITOS O CUALQUIER OTRAS CELULAS INFECTADAS CON EL VIRUS.
ES93915244T 1992-06-10 1993-06-10 Peptido estimulante de linfocitos t citotoxicos especificos de virus de la hepatitis c. Expired - Lifetime ES2104156T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/894,063 US5980899A (en) 1992-06-10 1992-06-10 Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells

Publications (1)

Publication Number Publication Date
ES2104156T3 true ES2104156T3 (es) 1997-10-01

Family

ID=25402543

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93915244T Expired - Lifetime ES2104156T3 (es) 1992-06-10 1993-06-10 Peptido estimulante de linfocitos t citotoxicos especificos de virus de la hepatitis c.

Country Status (11)

Country Link
US (1) US5980899A (es)
EP (1) EP0644894B1 (es)
JP (1) JP3510249B2 (es)
AT (1) ATE153031T1 (es)
AU (1) AU669193B2 (es)
CA (1) CA2135278C (es)
DE (1) DE69310734T2 (es)
DK (1) DK0644894T3 (es)
ES (1) ES2104156T3 (es)
GR (1) GR3024462T3 (es)
WO (1) WO1993025575A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5709995A (en) 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
AU773000C (en) * 1994-07-27 2004-10-07 Csl Limited Polyepitope vaccines
EP0769963A4 (en) * 1994-07-27 1999-07-28 Commw Scient Ind Res Org POLYEPITOPE VACCINES
US5767233A (en) * 1995-05-12 1998-06-16 Schering Corporation Soluble cleavable substrates of the hepatitis C virus protease
GB9618119D0 (en) 1996-08-30 1996-10-09 Univ Southampton Adjuvants for use in vaccines
CA2312484A1 (en) 1997-12-11 1999-06-17 Smithkline Beecham Corporation Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
WO2001021189A1 (en) * 1999-07-19 2001-03-29 Epimmune Inc. Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
JP2004503205A (ja) 2000-02-04 2004-02-05 デューク・ユニバーシティー ヒト免疫不全ウイルスワクチン
AU2001246393A1 (en) * 2000-03-31 2001-10-08 Vaccine Chip Technology Aps Immunostimulating properties of a fragment of tgf-beta
WO2002020035A1 (en) * 2000-09-01 2002-03-14 Epimmune Inc. Hla binding peptides and their uses
US7326536B2 (en) * 2001-05-03 2008-02-05 Eli Lilly And Company Agents for treatment of HCV and methods of use
FR2828934B1 (fr) * 2001-08-27 2004-08-13 Inst Nat Sante Rech Med Test de l'immunite cellulaire par des peptides fixes sur support solide
EP1357127A1 (de) * 2002-04-10 2003-10-29 Immusystems GmbH CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
CA2566506A1 (en) * 2004-06-01 2005-12-15 Innogenetics N.V. Peptides for inducing a ctl and/or htl response to hepatitis c virus
US20070073039A1 (en) * 2005-09-29 2007-03-29 Chisari Francis V Peptides that inhibit viral infections
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
EP3765075A4 (en) * 2018-03-16 2021-12-08 The Governors of the University of Alberta HEPATITIS C VIRUS PEPTIDE COMPOSITIONS AND METHOD OF USING THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
JPH02500880A (ja) * 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines

Also Published As

Publication number Publication date
CA2135278C (en) 2005-08-09
AU669193B2 (en) 1996-05-30
ATE153031T1 (de) 1997-05-15
JPH08501282A (ja) 1996-02-13
AU4530093A (en) 1994-01-04
US5980899A (en) 1999-11-09
CA2135278A1 (en) 1993-12-23
WO1993025575A1 (en) 1993-12-23
GR3024462T3 (en) 1997-11-28
EP0644894A1 (en) 1995-03-29
DE69310734D1 (de) 1997-06-19
DK0644894T3 (da) 1997-12-08
JP3510249B2 (ja) 2004-03-22
EP0644894B1 (en) 1997-05-14
DE69310734T2 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
ES2104156T3 (es) Peptido estimulante de linfocitos t citotoxicos especificos de virus de la hepatitis c.
ES2029171A6 (es) Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh)
ES2075901T3 (es) Sistemas de expresion de virus recombinantes de arn con cadena negativa y vacunas.
ES2012739T3 (es) Diagnosticos y vacunas para nanbv.
DK0992580T3 (da) Epitoper på human T-celler, som er immundominante for hepatitis C-virus
DE69133228D1 (de) Dna-expressionssysteme basierend auf alphaviren
ATE188998T1 (de) Hcv-isolat j-1
FI935808A0 (fi) Hepatit-C-virus (HCV) polypeptider
ES2078255T3 (es) Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16.
DK0644202T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
ATE309367T1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
ATA3552000A (de) Xylosyltransferase-gen
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
BR9815912A (pt) Cepa viral de hepatite b induzida por vacina e seus usos
DK35891D0 (da) Praktisk taget rent, antigenisk peptid eller protein med en epitop af haemophilus influenzae, dets fremstilling og anvendelse
DK0651806T3 (da) Vacciner imod katteimmundeficiensvirus (FIV)
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
DK0551275T3 (da) Non-A non-B sekvenser
NO912387D0 (no) Rent faktor 1-protein, samt fremgangsmaate for fremstilling av proteinet.
BR9815913A (pt) Cepa viral de hepatite b humana mutante e seususos
PT89041A (pt) Metodo de preparacao de diagnosticos e vacinas nanbv
Roscoe Presentation of vesicular stomatitis virus antigens to anti-vesicular stomatitis virus cytotoxic T lymphocytes
KR950000881A (ko) 새로운 한국형 씨(C)형 간염 바이러스 씨디엔에이(cDNA) 절편의 뉴클레오티드 서열 및 이로부터 유추된 아미노산 서열

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 644894

Country of ref document: ES